Lung cancer stem cells

Disease Markers

Volumn 24, Issue 4-5, 2008, Pages 257-266

  Pine, Sharon R ^a   Marshall, Blair ^b   Varticovski, Lyuba ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

ABC transporters; Drug resistance; Hedgehog; Non small cell lung cancer; Notch; Side population; Small cell lung cancer; Stem cells; Wnt

Indexed keywords

ABC TRANSPORTER; ALDEHYDE DEHYDROGENASE; ATAXIN 1; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CD34 ANTIGEN; DELTA LIKE 1 PROTEIN; DELTA LIKE 3 PROTEIN; DELTA LIKE 4 PROTEIN; JAGGED1; JAGGED2 PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; NOTCH1 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN HEY1; PROTEIN HEY2; PROTEIN HEYL; PROTEIN PATCHED; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR GLI3; TRANSCRIPTION FACTOR HES 1; WNT INHIBITORY FACTOR 1; WNT PROTEIN;

CANCER MODEL; CANCER RESISTANCE; CANCER STEM CELL; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CLARA CELL; CYTOLOGY; GENE EXPRESSION; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TISSUE REGENERATION;

ERINACEIDAE;

EID: 47849127670     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/396281     Document Type: Review

References (106)

1. S.A. Ahrendt, S.C. Yang, L. Wu, C.M. Roig, P. Russell, W.H. Westra, J. Jen, M.V. Brock, R.F. Heitmiller and D. Sidransky, Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study, J Thorac Cardiovasc Surg 123 (2002), 466-473.
2. A. Altaba, P. Sanchez and N. Dahmane, Gli and hedgehog in cancer: tumours, embryos and stem cells, Nat Rev Cancer 2 (2002), 361-372.
3. O. Altundag, K. Altundag, C. Boruban, Y.S. Silay and S. Turen, Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a Phase II clinical trial, Cancer 104 (2005), 2033-2034.
4. D.W. Ball, C.G. Azzoli, S.B. Baylin, D. Chi, S. Dou, H. Donis-Keller, A. Cumaraswamy, M. Borges and B.D. Nelkin, Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors, Proc Natl Acad Sci USA 90 (1993), 5648-5652.
5. C. Baum, L.J. Fairbairn, M. Hildinger, L.S. Lashford, S. Hegewisch-Becker and J.A. Rafferty, New perspectives for cancer chemotherapy by genetic protection of haematopoietic cells, Expert Rev Mol Med 1999 (1999), 1-28.
6. D. Beier, P. Hau, M. Proescholdt, A. Lohmeier, J. Wischhusen, P.J. Oefner, L. Aigner, A. Brawanski, U. Bogdahn and C.P. Beier, CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles, Cancer Res 67(9) (1 May 2007), 4040-4015.
7. S. Bellusci, J. Grindley, H. Emoto, N. Itoh and B.L. Hogan, Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung, Development 124 (1997), 4867-4878.
8. E. Ben Shushan, H. Sharir, E. Pikarsky and Y. Bergman, A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells, Mol Cell Biol 15 (1995), 1034-1048.
9. A. Berns, Stem cells for lung cancer? Cell 121 (2005), 811-813.
10. B. Bettenhausen, d.A. Hrabe, D. Simon, J.L. Guenet and A. Gossler, Transient and restricted expression during mouse embryogenesis of Dll1, a murine gene closely related to Drosophila Delta, Development 121 (1995), 2407-2418.
11. R.I. Bhatt, M.D. Brown, C.A. Hart, P. Gilmore, V.A. Ramani, N.J. George and N.W. Clarke, Novel method for the isolation and characterisation of the putative prostatic stem cell, Cytometry A 54 (2003), 89-99.
12. D. Bonnet and J.E. Dick, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat Med 3 (1997), 730-737.
13. M. Borges, R.I. Linnoila, H.J. van de Velde, H. Chen, B.D. Nelkin, M. Mabry, S.B. Baylin and D.W. Ball, An achaete-scute homologue essential for neuroendocrine differentiation in the lung, Nature 386 (1997), 852-855.
14. H. Chen, A. Thiagalingam, H. Chopra, M.W. Borges, J.N. Feder, B.D. Nelkin, S.B. Baylin and D.W. Ball, Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression, Proc Natl Acad Sci USA 94 (1997), 5355-5360.
15. R.B. Clarke, Isolation and characterization of human mammary stem cells, Cell Prolif 38 (2005), 375-386.
16. C.D. Coldren, B.A. Helfrich, S.E. Witta, M. Sugita, R. Lapadat, C. Zeng, A. Baron, W.A. Franklin, F.R. Hirsch, M.W. Geraci and P.A. Bunn, Jr., Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines, Mol Cancer Res 4 (2006), 521-528.
17. B.J. Collins, W. Kleeberger and D.W. Ball, Notch in lung development and lung cancer, Semin Cancer Biol 14 (2004), 357-364.
18. J.D. Crapo, B.E. Barry, P. Gehr, M. Bachofen and E.R. Weibel, Cell number and cell characteristics of the normal human lung, Am Rev Respir Dis 126 (1982), 332-337.
19. T.P. Dang, A.F. Gazdar, A.K. Virmani, T. Sepetavec, K.R. Hande, J.D. Minna, J.R. Roberts and D.P. Carbone, Chromosome 19 translocation, overexpression of Notch3, and human lung cancer, J Natl Cancer Inst 92 (2000), 1355-1357.
20. S.P. De Langhe, F.G. Sala, P.M. Del Moral, T.J. Fairbanks, K.M. Yamada, D. Warburton, R.C. Burns and S. Bellusci, Dickkopf-1 (DKK1) reveals that fibronectin is a major target of Wnt signaling in branching morphogenesis of the mouse embryonic lung, Dev Biol 277 (2005), 316-331.
21. P.P. Delsanto, M. Griffa, C.A. Condat, S. Delsanto and L. Morra, Bridging the Gap between mesoscopic and macroscopic models: the case of multicellular tumor spheroids, Phys Rev Lett 94 (2005), 148105.
22. B. Desai, M.J. Rogers and M.A. Chellaiah, Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells, Mol Cancer 6 (2007), 18.
23. G.K. Dy, A.A. Miller, S.J. Mandrekar, M.C. Aubry, R.M. Langdon, Jr., R.F. Morton, S.E. Schild, J.R. Jett and A.A. Adjei, A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study, Ann Oncol 16 (2005), 1811-1816.
24. J.A. Engelman, K. Zejnullahu, T. Mitsudomi, Y. Song, C. Hyland, J.O. Park, N. Lindeman, C.M. Gale, X. Zhao, J. Christensen, T. Kosaka, A.J. Holmes, A.M. Rogers, F. Cappuzzo, T. Mok, C. Lee, B.E. Johnson, L.C. Cantley and P.A. Janne, MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling, Science (2007).
25. A. Eramo, F. Lotti, G. Sette, E. Pilozzi, M. Biffoni, A. Di Virgilio, C. Conticello, L. Ruco, C. Peschle and R. De Maria, Identification and expansion of the tumorigenic lung cancer stem cell population, Cell Death Differ 15 (2008), 504-514.
26. M. Evangelista, H. Tian and F.J. De Sauvage, The hedgehog signaling pathway in cancer, Clin Cancer Res 12 (2006), 5924-5928.
27. G. Feldmann, S. Dhara, V. Fendrich, D. Bedja, R. Beaty, M. Mullendore, C. Karikari, H. Alvarez, C. Iacobuzio-Donahue, A. Jimeno, K.L. Gabrielson, W. Matsui and A. Maitra, Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers, Cancer Res 67 (2007), 2187-2196.
28. C.M. Ferrell, S.T. Dorsam, H. Ohta, R.K. Humphries, M.K. Derynck, C. Haqq, C. Largman and H.J. Lawrence, Activation of stem-cell specific genes by HOXA9 and HOXA10 homeodomain proteins in CD34+ human cord blood cells, Stem Cells 23 (2005), 644-655.
29. I. Fishel, A. Kaufman and E. Ruppin, Meta-Analysis of Gene Expression Data: A Predictor-Based Approach, Bioinformatics (2007).
30. E. Gabrielson, Worldwide trends in lung cancer pathology, Respirology 11 (2006), 533-538.
31. + hematopoietic stem- progenitor cell microRNA expression and function: a circuit diagram of differentiation control, Proc Natl Acad Sci USA 104 (2007), 2750-2755.
32. A. Giangreco, S.D. Reynolds and B.R. Stripp, Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction, Am J Pathol 161 (2002), 173-182.
33. K.L. Grinnell, B. Yang, R.L. Eckert and J.R. Bickenbach, De-differentiation of mouse interfollicular keratinocytes by the embryonic transcription factor Oct-4, J Invest Dermatol 127 (2007), 372-380.
34. D.J. Gross, G. Munter, M. Bitan, T. Siegal, A. Gabizon, R. Weitzen, O. Merimsky, A. Ackerstein, A. Salmon, A. Sella and S. Slavin, The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R, Endocr Relat Cancer 13 (2006), 535-540.
35. M. Gutova, J. Najbauer, A. Gevorgyan, M.Z. Metz, Y. Weng, C.C. Shih and K.S. Aboody, Identification of uPAR-positive Chemoresistant Cells in Small Cell Lung Cancer, PLoS ONE 2 (2007), e243.
36. E.M. Hansson, U. Lendahl and G. Chapman, Notch signaling in development and disease, Semin Cancer Biol 14 (2004), 320-328.
37. D.H. Harpole and S.L. Meyerson, Lung cancer staging: proteomics, Thorac Surg Clin 16 (2006), 339-343.
38. S. Hatfield and H. Ruohola-Baker, microRNA and stem cell function, Cell Tissue Res 331 (2008), 57-66.
39. B. He, R.N. Barg, L. You, Z. Xu, N. Reguart, I. Mikami, S. Batra, R. Rosell and D.M. Jablons, Wnt signaling in stem cells and non-small-cell lung cancer, Clin Lung Cancer 7 (2005), 54-60.
40. K. Hibi, T. Takahashi, Y. Sekido, R. Ueda, T. Hida, Y. Ariyoshi, H. Takagi and T. Takahashi, Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer, Oncogene 6(12) (Dec 1991), 2291-2296.
41. C. Hirschmann-Jax, A.E. Foster, G.G. Wulf, J.G. Nuchtern, T.W. Jax, U. Gobel, M.A. Goodell and M.K. Brenner, A distinct "side population" of cells with high drug efflux capacity in human tumor cells, Proc Natl Acad Sci USA 101 (2004), 14228-14233.
42. M.M. Ho, A.V. Ng, S. Lam and J.Y. Hung, Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells, Cancer Res 67 (2007), 4827-4833.
43. K.U. Hong, S.D. Reynolds, S. Watkins, E. Fuchs and B.R. Stripp, Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium, Am J Pathol 164 (2004), 577-588.
44. T. Ito, N. Udaka, T. Yazawa, K. Okudela, H. Hayashi, T. Sudo, F. Guillemot, R. Kageyama and H. Kitamura, Basic helix-loop-helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium, Development 127 (2000), 3913-3921.
45. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu and M.J. Thun, Cancer statistics, 2007, CA Cancer J Clin 57 (2007), 43-66.
46. T.A. Juopperi, W. Schuler, X. Yuan, M.I. Collector, C.V. Dang and S.J. Sharkis, Isolation of bone marrow-derived stem cells using density-gradient separation, Exp Hematol 35 (2007), 335-341.
47. Y. Kang, M. Omura, A. Suzuki, T. Oka, Y. Nakagami, C. Cheng, Y. Nagashima and T. Inoue, Development of an orthotopic transplantation model in nude mice that simulates the clinical features of human lung cancer, Cancer Sci 97 (2006), 996-1001.
48. H. Kato, Y. Ichinose, M. Ohta, E. Hata, N. Tsubota, H. Tada, Y. Watanabe, H. Wada, M. Tsuboi, N. Hamajima and M. Ohta, A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung, N Engl J Med 350 (2004), 1713-1721.
49. C.F. Kim, E.L. Jackson, A.E. Woolfenden, S. Lawrence, I. Babar, S. Vogel, D. Crowley, R.T. Bronson and T. Jacks, Identification of bronchioalveolar stem cells in normal lung and lung cancer, Cell 121 (2005), 823-835.
50. J. Kim, L. You, Z. Xu, K. Kuchenbecker, D. Raz, B. He and D. Jablons, Wnt inhibitory factor inhibits lung cancer cell growth, J Thorac Cardiovasc Surg 133 (2007), 733-737.
51. N. Kim and T.H. Vu, Parabronchial smooth muscle cells and alveolar myofibroblasts in lung development, Birth Defects Res C Embryo Today 78 (2006), 80-89.
52. T. Kondo, T. Setoguchi and T. Taga, Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line, Proc Natl Acad Sci USA 101 (2004), 781-786.
53. M. Lako, T. Strachan, P. Bullen, D.I. Wilson, S.C. Robson and S. Lindsay, Isolation, characterisation and embryonic expression of WNT11, a gene which maps to 11q13.5 and has possible roles in the development of skeleton, kidney and lung, Gene 219 (1998), 101-110.
54. W.K. Lam, Lung cancer in Asian women-the environment and genes, Respirology 10 (2005), 408-417.
55. Q.T. Le, E. Chen, A. Salim, H. Cao, C.S. Kong, R. Whyte, J. Donington, W. Cannon, H. Wakelee, R. Tibshirani, J.D. Mitchell, D. Richardson, K.J. O'Byrne, A.C. Koong and A.J. Giaccia, An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers, Clin Cancer Res 12 (2006), 1507-1514.
56. L.N. Lee, S.H. Kuo, Y.C. Lee, Y.L. Chang, H.C. Chang, I.S. Jan and P.C. Yang, CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma, J Formos Med Assoc 104 (2005), 541-548.
57. C. Leimeister, A. Externbrink, B. Klamt and M. Gessler, Hey genes: a novel subfamily of hairy- and Enhancer of split related genes specifically expressed during mouse embryogenesis, Mech Dev 85 (1999), 173-177.
58. C. Li, J. Xiao, K. Hormi, Z. Borok and P. Minoo, Wnt5a participates in distal lung morphogenesis, Dev Biol 248 (2002), 68-81.
59. E. Lim, Y.K. Yap, B.L. De Stavola, A.G. Nicholson and P. Goldstraw, The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors, J Thorac Cardiovasc Surg 130 (2005), 969-972.
60. Y. Litingtung, L. Lei, H. Westphal and C. Chiang, Sonic hedgehog is essential to foregut development, Nat Genet 20 (1998), 58-61.
61. J. Liu and G. Jiang, CD44 and hematologic malignancies, Cell Mol Immunol 3 (2006), 359-365.
62. W.J. Mackillop, A. Ciampi, J.E. Till and R.N. Buick, A stem cell model of human tumor growth: implications for tumor cell clonogenic assays, J Natl Cancer Inst 70 (1983), 9-16.
63. S.M. Majka, M.A. Beutz, M. Hagen, A.A. Izzo, N. Voelkel and K.M. Helm, Identification of novel resident pulmonary stem cells: form and function of the lung side population, Stem Cells 23 (2005), 1073-1081.
64. J.D. Minna, J.A. Roth and A.F. Gazdar, Focus on lung cancer, Cancer Cell 1 (2002), 49-52.
65. N. Mitsutake, A. Iwao, K. Nagai, H. Namba, A. Ohtsuru, V. Saenko and S. Yamashita, Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively, Endocrinology 148 (2007), 1797-1803.
66. D. Naor, S. Nedvetzki, I. Golan, L. Melnik and Y. Faitelson, CD44 in cancer, Crit Rev Clin Lab Sci 39 (2002), 527-579.
67. T.G. Natarajan and K.T. FitzGerald, Markers in normal and cances stem cells, Cancer Biomarkers 3 (2007), 211-231.
68. J. Neuzil, M. Stantic, R. Zobalova, J. Chladova, X. Wang, L. Prochazka, L. Dong, L. Andera and S.J. Ralph, Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name? Biochem Biophys Res Commun 355 (2007), 855-859.
69. R. Pardal, M.F. Clarke and S.J. Morrison, Applying the principles of stem-cell biology to cancer, Nat Rev Cancer 3 (2003), 895-902.
70. D.M. Parkin, P. Pisani and J. Ferlay, Estimates of the worldwide incidence of 25 major cancers in 1990, Int J Cancer 80 (1999), 827-841.
71. D.J. Pearce, D. Taussig, C. Simpson, K. Allen, A.Z. Rohatiner, T.A. Lister and D. Bonnet, Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples, Stem Cells 23 (2005), 752-760.
72. G. Pelosi, M. Barisella, F. Pasini, M.E. Leon, G. Veronesi, L. Spaggiari, F. Fraggetta, A. Iannucci, M. Masullo, A. Sonzogni, F. Maffini and G. Viale, CD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung: relevance to prognosis in a subset of adenocarcinoma patients, Mod Pathol 17 (2004), 711-721.
73. M. Pesce and H.R. Scholer, Oct-4: gatekeeper in the beginnings of mammalian development, Stem Cells 19 (2001), 271-278.
74. E. Pisick, S. Jagadeesh and R. Salgia, Small cell lung cancer: from molecular biology to novel therapeutics, J Exp Ther Oncol 3 (2003), 305-318.
75. J.E. Pongracz and R.A. Stockley, Wnt signalling in lung development and diseases, Respir Res 7 (2006), 15.
76. L.C. Post, M. Ternet and B.L. Hogan, Notch/Delta expression in the developing mouse lung, Mech Dev 98 (2000), 95-98.
77. A. Potti, S. Mukherjee, R. Peterson, H.K. Dressman, A. Bild, J. Koontz, R. Kratzke, M.A. Watson, M. Kelley, G.S. Ginsburg, M.West, D.H. Harpole, Jr. and J.R. Nevins, A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer, The New England Journal of Medicine 355 (2006), 570-580.
78. T. Reya, S.J. Morrison, M.F. Clarke and I.L.Weissman, Stem cells, cancer, and cancer stem cells, Nature 414 (2001), 105-111.
79. S.D. Reynolds, A. Giangreco, J.H. Power and B.R. Stripp, Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration, Am J Pathol 156 (2000), 269-278.
80. S.D. Reynolds, H. Shen, P.R. Reynolds, T. Betsuyaku, J.M. Pilewski, F. Gambelli, M. Deguiseppe, L.A. Ortiz and B.R. Stripp, Molecular and functional properties of lung SP cells, Am J Physiol Lung Cell Mol Physiol 292 (2007), L972-L983.
81. J. Russo, A. Barnes, K. Berger, J. Desgrosellier, J. Henderson, A. Kanters and L. Merkov, 4-(N,N-dipropylamino)benzaldehyde inhibits the oxidation of all-trans retinal to all-trans retinoic acid by ALDH1A1, but not the differentiation of HL-60 promyelocytic leukemia cells exposed to all-trans retinal, BMC Pharmacol 2 (2002), 4.
82. G.V. Scagliotti, F. Michelotto, G. Kalikatzaros, E. Leonardo, S. Cappia, L. Gubetta, P. Borasio and E. Pozzi, Detection of multidrug resistance associated P-170 glycoprotein in previously untreated non small cell lung cancer, Anticancer Res 11 (1991), 2207-2210.
83. J.B. Schnier, G. Kaur, A. Kaiser, S.F. Stinson, E.A. Sausville, J. Gardner, K. Nishi, E.M. Bradbury and A.M. Senderowicz, Identification of cytosolic aldehyde dehydrogenase 1 from non-small cell lung carcinomas as a flavopiridol-binding protein, FEBS Lett 454 (1999), 100-104.
84. L.V. Sequist, D.W. Bell, T.J. Lynch and D.A. Haber, Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer, J Clin Oncol 25 (2007), 587-595.
85. S.V. Shmelkov, R. St Clair, D. Lyden and S. Rafii, AC133/CD133/Prominin- 1, Int J Biochem Cell Biol 37 (2005), 715-719.
86. W. Shu, Y.Q. Jiang, M.M. Lu and E.E. Morrisey, Wnt7b regulates mesenchymal proliferation and vascular development in the lung, Development 129 (2002), 4831-4842.
87. G.H. Smith, Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands, Development 132 (2005), 681-687.
88. V. Sriuranpong, M.W. Borges, R.K. Ravi, D.R. Arnold, B.D. Nelkin, S.B. Baylin and D.W. Ball, Notch signaling induces cell cycle arrest in small cell lung cancer cells, Cancer Res 61 (2001), 3200-3205.
89. V. Sriuranpong, M.W. Borges, C.L. Strock, E.K. Nakakura, D.N.Watkins, C.M. Blaumueller, B.D. Nelkin and D.W. Ball, Notch signaling induces rapid degradation of achaete-scute homolog 1, Mol Cell Biol 22 (2002), 3129-3139.
90. C. Steidl, C. Leimeister, B. Klamt, M. Maier, I. Nanda, M. Dixon, R. Clarke, M. Schmid and M. Gessler, Characterization of the human and mouse HEY1, HEY2, and HEYL genes: cloning, mapping, and mutation screening of a new bHLH gene family, Genomics 66 (2000), 195-203.
91. R. Summer, D.N.Kotton, X. Sun, B. Ma, K. Fitzsimmons and A. Fine, Side population cells and Bcrp1 expression in lung, Am J Physiol Lung Cell Mol Physiol 285 (2003), L97-104.
92. K. Uematsu, B. He, L. You, Z. Xu, F. McCormick and D.M. Jablons, Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression, Oncogene 22 (2003), 7218-7221.
93. D.M. van der, E.G. de Vries, W. Timens, R.J. Scheper, H. Timmer-Bosscha and D.S. Postma, ATP-binding cassette (ABC) transporters in normal and pathological lung, Respir Res 6 (2005), 59.
94. A.L.Vescovi, R. Galli and B.A. Reynolds, Brain tumour stem cells, Nat Rev Cancer 6 (2006), 425-436.
95. J. Vestergaard, M.W. Pedersen, N. Pedersen, C. Ensinger, Z. Tumer, N. Tommerup, H.S. Poulsen and L.A. Larsen, Hedgehog signaling in small-cell lung cancer: frequent in vivo but a rare event in vitro, Lung Cancer 52 (2006), 281-290.
96. Z. Wang, W. Shu, M.M. Lu and E.E. Morrisey, Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5, Mol Cell Biol 25 (2005), 5022-5030.
97. D. Warburton, S. Bellusci, S. De Langhe, P.M. Del Moral, V. Fleury, A. Mailleux, D. Tefft, M. Unbekandt, K. Wang and W. Shi, Molecular mechanisms of early lung specification and branching morphogenesis, Pediatr Res 57 (2005), 26R-37R.
98. D. Warburton, C. Wuenschell, G. Flores-Delgado and K. Anderson, Commitment and differentiation of lung cell lineages, Biochem Cell Biol 76 (1998), 971-995.
99. D.N. Watkins, D.M. Berman, S.G. Burkholder, B. Wang, P.A. Beachy and S.B. Baylin, Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer, Nature 422 (2003), 313-317.
100. I.L. Weissman, D.J. Anderson and F. Gage, Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations, Annu Rev Cell Dev Biol 17 (2001), 387-403.
101. T. Winton, R. Livingston, D. Johnson, J. Rigas, M. Johnston, C. Butts, Y. Cormier, G. Goss, R. Inculet, E.Vallieres, W. Fry, D. Bethune, J. Ayoub, K. Ding, L. Seymour, B. Graham, M.S. Tsao, D. Gandara, K. Kesler, T. Demmy and F. Shepherd, Vinorelbine plus cisplatin vs. observation in resected nonsmall-cell lung cancer, N Engl J Med 352 (2005), 2589-2597.
102. E.L. Wynder and J.E. Muscat, The changing epidemiology of smoking and lung cancer histology, Environ Health Perspect 103(Suppl 8) (1995), 143-148.
103. S. Yanagi, H. Kishimoto, K. Kawahara, T. Sasaki, M. Sasaki, M. Nishio, N. Yajima, K. Hamada, Y. Horie, H. Kubo, J.A. Whitsett, T.W. Mak, T. Nakano, M. Nakazato and A. Suzuki, Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice, J Clin Invest 117 (2007), 2929-2940.
104. N. Yanaihara, N. Caplen, E. Bowman, M. Seike, K. Kumamoto, M. Yi, R.M. Stephens, A. Okamoto, J. Yokota, T. Tanaka, G.A. Calin, C.G. Liu, C.M. Croce and C.C. Harris, Unique microRNA molecular profiles in lung cancer diagnosis and prognosis, Cancer Cell 9 (2006), 189-198.
105. L. You, B. He, Z. Xu, K. Uematsu, J. Mazieres, I. Mikami, N. Reguart, T.W. Moody, J. Kitajewski, F. McCormick and D.M. Jablons, Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells, Oncogene 23 (2004), 6170-6174.
106. S. Zhou, J.J. Morris, Y. Barnes, L. Lan, J.D. Schuetz and B.P. Sorrentino, Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo, Proc Natl Acad Sci USA 99 (2002), 12339-12344.